![](/img/cover-not-exists.png)
435P Development of PF-06439535, a potential biosimilar to bevacizumab
Jacobs, I.A., Brown, P.R., Knight, B., Peraza, M.A., Rosenberg, J.A., Rule, K.Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw593.005
Date:
December, 2016
File:
PDF, 38 KB
english, 2016